On the fourth anniversary of New Zealand’s first COVID case it’s clear this is not a normal pandemic. Despite fatigue and indifference, New Zealand must heed the evidence and improve its response.
Here’s why it’s taken so long to develop a vaccine for respiratory syncytial virus and what we can expect next.
Only one antiviral medication is approved by the FDA for RSV treatment, and it is administered through a nebulizer.
BonNontawat/iStock via Getty Images Plus
Understanding how injury and disease, including COVID-19, can impair lung function can help researchers and clinicians better help patients who are experiencing chronic conditions
The immune system usually stays dormant in the lungs in times of health.
wildpixel/iStock via Getty Images
While a strong immune response is essential to fight against viral infection, an immune system that continues to stay active long after the virus has been cleared can lead to lung damage.
ECMO uses an artificial heart and lung to replace the entire function of the person’s own heart and lungs outside the body. And COVID is demanding more ECMO than we’ve ever used before.
Higher temperatures cause drought, and can lead to food insecurity.
Guido Dingemans, De Eindredactie/GettyImages
Many of the temperatures presently being recorded in Africa, and those projected in the next decade, are already close to the limits of human survival, or “liveability”.
It causes fever, a dry cough, shortness of breath. Outbreaks are frequently deadly. It’s not COVID-19, and it could be waiting in your workplace after lockdown.
President Donald Trump has been widely slammed for mishandling the COVID-19 crisis, costing the US dearly.
Drew Angerer/Getty Images